Locus Bioscience
  • Platforms
  • Programs
  • Manufacturing
  • Careers
  • About Us
  • Newsroom
Contact
Media

Press Release

15 Articles found
News Press Releases Locus Insights

Posts pagination

Prev 1 2
  • July 17, 2018

    Locus Biosciences acquires EpiBiome’s high-throughput discovery platform to enhance its global leadership in CRISPR-engineered phage therapeutics

    Learn More
  • January 3, 2018

    Locus Biosciences and IDbyDNA Partner to Develop Companion Diagnostic Test for Pseudomonas aeruginosa Infection

    Learn More
  • November 14, 2017

    Locus Biosciences Closes $19 Million Series A Led by ARTIS Ventures for CRISPR-Cas3 Antimicrobials

    Learn More
  • July 10, 2017

    Locus Biosciences Secures $5m Convertible Note for CRISPR-Cas3 Antimicrobials : PR Newswire

    Learn More
  • April 10, 2017

    Locus Biosciences Announces Appointments of Dr. Casey Theriot and Dr. Daniel Pomp to its Science Advisory Board

    Learn More

Posts pagination

Prev 1 2

Careers

We are on a mission to revolutionize the treatment of disease. We need intelligent, open, hard-working people who thrive in a fast-paced environment to join us on our quest.

Join Our Team

Media Inquiries


For all media inquiries, please contact
our public relations agency below

Contact Now
Locus Biosciences

Precision Medicines for Bacterial Infections
and Immunologic Diseases

Home

Platform

Programs

Manufacturing

Careers

About Us

Newsroom

Contact Us

Location

523 Davis Drive Suite 350
Morrisville NC 27560

Email

info@locus-bio.com

Linkedin

Linkedin

Twitter

Twitter

©Copyright 2025 Locus Biosciences, Inc. All rights reserved.

powered by wildfire